180 related articles for article (PubMed ID: 25936343)
1. Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma.
Kong G; Liu Z; Wu K; Zhang Y; Deng Z; Feng W; Chen S; Wang H
Tumour Biol; 2015 Sep; 36(10):7735-41. PubMed ID: 25936343
[TBL] [Abstract][Full Text] [Related]
2. High PITX1 expression in lung adenocarcinoma patients is associated with DNA methylation and poor prognosis.
Song X; Zhao C; Jiang L; Lin S; Bi J; Wei Q; Yu L; Zhao L; Wei M
Pathol Res Pract; 2018 Dec; 214(12):2046-2053. PubMed ID: 30322808
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
[TBL] [Abstract][Full Text] [Related]
4. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
5. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma.
Shen A; Zhang Y; Yang H; Xu R; Huang G
J Surg Oncol; 2012 Jun; 105(8):830-4. PubMed ID: 22213004
[TBL] [Abstract][Full Text] [Related]
7. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.
Li Y; Nakka M; Kelly AJ; Lau CC; Krailo M; Barkauskas DA; Hicks JM; Man TK
Cancer Res; 2016 Jul; 76(13):4002-11. PubMed ID: 27197201
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
Xie Y; Huang J; Wu M; Zhou Y
J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.
Bao ZQ; Zhang CC; Xiao YZ; Zhou JS; Tao YS; Chai DM
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):193-199. PubMed ID: 27072961
[TBL] [Abstract][Full Text] [Related]
10. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
13. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.
Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q
Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383
[TBL] [Abstract][Full Text] [Related]
16. Expression of MSH2 and MSH6 on a tissue microarray in patients with osteosarcoma.
Jentzsch T; Robl B; Husmann M; Bode-Lesniewska B; Fuchs B
Anticancer Res; 2014 Dec; 34(12):6961-72. PubMed ID: 25503122
[TBL] [Abstract][Full Text] [Related]
17. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
20. Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients.
Zhao YX; Gao ST; Wang JQ; Yao WT; Wang YS; Guo CL
Med Sci Monit; 2017 Feb; 23():665-672. PubMed ID: 28163298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
